Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.

OBJECTIVE To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.

• Publication year

  2011

• Venue

  Diabetes Care

• Publication date

  2011-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc11-1108PMID 21852677PMCID 3177727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence-based guideline: Treatment of painful diabetic neuropathy

  2011cited by this paper
• Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

  2011cited by this paper
• Prevalence of Peripheral Neuropathy and Painful Peripheral Neuropathy in Turkish Diabetic Patients

  2011cited by this paper
• Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia

  2010influential reference
• Neuropathy of Impaired Glucose Tolerance and Its Measurement

  2010cited by this paper
• Explanations for the Lower Rates of Diabetic Neuropathy in Indian Asians Versus Europeans

  2010cited by this paper
• Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort

  2009cited by this paper
• Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre‐diabetes and diabetes. The KORA Myocardial Infarction Registry

  2009cited by this paper
• The natural history of chronic painful peripheral neuropathy in a community diabetes population

  2006influential reference
• Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study.

  2005cited by this paper
• The global burden of diabetic foot disease.

  2005cited by this paper
• Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

  2004influential reference
• Neuropathic Pain Questionnaire—Short Form

  2003cited by this paper
• Foot complications in Type 2 diabetes: an Australian population‐based study

  2003cited by this paper
• The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort

  2002cited by this paper
• The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups

  1998cited by this paper
• Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study

  1996cited by this paper
• Painful Neuropathy and Foot Ulceration in Diabetic Patients

  1993cited by this paper
• A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

  1993cited by this paper

• EFFECT OF PROPRIOCEPTIVE TRAINING ON BALANCE, FUNCTIONAL MOBILITY, AND PAIN IN PATIENTS WITH DIABETIC NEUROPATHY: A RANDOMIZED CONTROLLED TRIAL

  2026cites this paper
• Mechanisms and Clinical Application Progress of Exercise in the Treatment of Neuropathic Pain

  2026cites this paper
• Immunological mechanisms and therapeutic advances in diabetic neuropathy

  2026cites this paper
• mTOR Signalling in Diabetic Peripheral Neuropathy: Balancing Neuropathic Pain and Schwann Cell-Mediated Repair

  2026cites this paper
• Neurologic Complications of Endocrine Disorders.

  2026cites this paper
• Glial Triad in Diabetic Neuropathy: Central Players in Neuropathic Pain Pathogenesis and Disease-Modifying Therapeutic Avenues.

  2026cites this paper
• Oxymatrine alleviates symptoms in high-fat diet and STZ-induced SD rats with painful diabetic neuropathy by reducing inflammation and oxidative stress.

  2026cites this paper
• Cerebral alterations associated with painful diabetic peripheral neuropathy

  2026cites this paper
• Relationship Between Elevated Plasma Homocysteine Levels and Severity of Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Analysis.

  2026cites this paper
• A Pragmatic Approach to Improving Management and Patient Flow for Painful Diabetic Neuropathy in UK Primary Care

  2025cites this paper
• Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis

  2025cites this paper
• Up-regulation of acid-sensing ion channel 1a in the anterior cingulate cortex by TNF-α/NF-κB pathway contributes to diabetes-related pain.

  2025cites this paper
• Statin therapy and neuropathy in type 1 diabetes: A cross‐sectional study

  2025cites this paper
• Physical Activity in the Management of Diabetic Neuropathic Pain: A Narrative Review of Mechanisms, Evidence, and Clinical Perspectives

  2025cites this paper
• Disrupted spatial but not temporal aspects of nociceptive processing determine painful polyneuropathies.

  2025cites this paper
• Corneal Nerve Morphology in Painful Diabetic Neuropathy: A Meta-Analysis of In Vivo Confocal Microscopy Studies

  2025influential citation
• Unmet Needs in Diabetic Distal Symmetric Polyneuropathy: A Cross-sectional Analysis from a Tertiary Care Diabetes Centre in Sri Lanka

  2025cites this paper
• Drug Usability Survey (DUS) of Gabapentinoid and Its Combinations Among Indian Patients With Neuropathic Pain: Results From a Real-World, Multicenter, Retrospective Survey at Neurology Clinics

  2025cites this paper
• Assessing the efficacy of methanol extracts of Ocimum sanctum linn. and Ocimum basilicum linn. in diabetic neuropathy

  2025cites this paper
• Prevalência de neuropatia diabética em indivíduos com diabetes mellitus e fatores de risco associados

  2025cites this paper
• The applications and mechanisms of Rosmarinus officinalis L. in the management of different wounds and UV-irradiated skin

  2025cites this paper
• SIRT1 Attenuates Neuropathic Pain via CDK5-Kalirin-7 Signaling Pathway in Type 2 Diabetic Rats

  2025cites this paper
• Serum neurofilament light chain and structural and Functional nerve fiber loss in painful and painless diabetic polyneuropathy.

  2025cites this paper
• Neural networks involved in painful diabetic neuropathy: A systematic review

  2025cites this paper
• The bradykinin-1 receptor antagonist fulmetibant in patients with diabetic neuropathic pain: the randomized, crossover, placebo-controlled, double-blind, phase 2a BRADiNP study.

  2025cites this paper
• Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study.

  2025cites this paper
• Potassium channel dysfunction and distinct sensory axonal profiles in painful type 2 diabetes.

  2025cites this paper
• Deep Learning-Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy.

  2025cites this paper
• Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain

  2025cites this paper
• Intravenous Streptozotocin Induces Variants in Painful Diabetic Peripheral Neuropathy in Female Mice

  2025cites this paper
• Diabetic peripheral neuropathy: Role of nitric oxide.

  2025cites this paper
• The role and mechanisms of matrix metalloproteinase-9 in peripheral neuropathic pain

  2025cites this paper
• DIAGNÓSTICO

  2025cites this paper
• Efeitos a longo prazo da estimulação da medula espinal em pacientes com neuropatia diabética: uma revisão sistemática

  2025cites this paper
• Painful diabetic neuropathy complicated with secondary erythromelalgia in polycythemia vera: A case report

  2025influential citation
• Efficacy and Safety of Ca2+ Channel α2δ Ligands for the Treatment of Diabetic Peripheral Neuropathic Pain: A Systematic Review and Network Meta-analysis

  2025cites this paper
• Ivabradine, a hyperpolarization-activated channel blocker, attenuates mechanical, but not heat, hypersensitivity in hyperglycemic and normoglycemic rat models of diabetic neuropathy.

  2025cites this paper
• miR‐27a‐3p Upregulation and Netrin‐1 Deficiency Drive Inflammatory Responses and Nerve Degeneration in Patients With Diabetes

  2025cites this paper
• A systematic review of outcomes measured in interventional trials in people with diabetic sensorimotor polyneuropathy

  2025cites this paper
• Comparison of Diabetic Polyneuropathy and Cardiac Autonomic Neuropathy in Type 1 and Type 2 Diabetes Mellitus

  2025cites this paper
• Prevalence and risk factors of painful diabetic neuropathy: A systematic review and meta-analysis.

  2025cites this paper
• Cytokine Signaling in Diabetic Neuropathy: A Key Player in Peripheral Nerve Damage

  2025cites this paper
• Unraveling the link between magnesium and diabetic neuropathy: Evidence from in vitro to clinical studies.

  2025cites this paper
• Plasma Fetuin-B Levels are Associated with Nervous Symptoms and Conduction Velocity in Patients with Painful DPN

  2025cites this paper
• Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: a randomized controlled study

  2025cites this paper
• Intravenous streptozotocin induces variants in painful diabetic peripheral neuropathy in female mice

  2025cites this paper
• Neuroprotective effects of semaglutide and metformin against rotenone-induced neurobehavioral changes in male diabetic rats

  2025cites this paper
• Heterogeneity in the development of diabetes-related complications: narrative review of the roles of ancestry and geographical determinants

  2025cites this paper
• Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review

  2025cites this paper
• Glial fibrillary acidic protein: a potential biomarker for small fiber neuropathy?

  2025cites this paper
• Involvement of TRPV1 and MOR-NMDAR complex on the antiallodynic effect of LMH-2, a sigma-1 receptor antagonist, in mouse model of diabetic neuropathy - a behavioral approach

  2025cites this paper
• Diabetic neuropathy: cutting-edge research and future directions

  2025influential citation
• A prospective study of small fiber neuropathy in AL amyloidosis

  2025cites this paper
• Network Meta-analysis of Randomized Controlled Trials Assessing Neuromodulation Therapies for Painful Diabetic Neuropathy

  2025cites this paper
• Causal Central Network Remodeling in Diabetic Neuropathy: An Integrated MR-fMRI Study

  2025cites this paper
• Spinal cord stimulation for the treatment of painful diabetic neuropathy and risk of major adverse cardiovascular events, mortality, amputation, infection and suicide: a retrospective cohort study

  2025cites this paper
• The Association Between Detailed Obesity Measurements and Peripheral Neuropathy in Persons With Diabetes

  2025cites this paper
• Early Diagnosis of Diabetic Neuropathy: A Review of Current Diagnostic Tests

  2025cites this paper
• The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in China

  2025cites this paper
• Impact of diabetes mellitus on spinal injection two-week outcomes in patients with predominant lower extremity pain

  2025cites this paper
• Impact of Exercise Training in Patients with Diabetic Peripheral Neuropathy: An Umbrella Review

  2025cites this paper
• Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

  2025cites this paper
• Efficacy of Frequency Rhythmic Electrical Modulated System (FREMS) in the treatment of diabetic neuropathy: A systematic review and meta-analysis of randomized controlled trials.

  2025cites this paper
• Efficacy and Safety of Once‐Daily Prolonged‐Release Pregabalin for the Treatment of Patients With Diabetic Peripheral Neuropathy: A Randomized, Double‐Blind, Active, and Placebo‐Controlled Trial

  2025cites this paper
• Trained immunity: novel perspectives in diabetes and associated complications

  2025cites this paper
• Structural and functional brain abnormal alteration in patients with type 2 diabetes mellitus: A coordinate-based meta-analysis

  2025cites this paper
• Long-lasting and fast methylglyoxal-scavenging peptide CycK(Myr)R4E alleviates chronic pain in type 2 diabetic mice

  2025cites this paper
• Sex Differences in Cardiovascular Risk and Diabetic Polyneuropathy: A Single-Center Retrospective Study in North-Eastern Hungary

  2025cites this paper
• EEG neurofeedback for the treatment of neuropathic pain in the elderly-a mechanistic review.

  2025cites this paper
• Diabetic Neuropathy Part 1: Overview and Symmetric Phenotypes.

  2025cites this paper
• Keratinocyte-Derived Exosomes in Painful Diabetic Neuropathy

  2024cites this paper
• Bibliometric analysis of research on the utilization of nanotechnology in diabetes mellitus and its complications.

  2024cites this paper
• Targeting TANK-binding kinase 1 attenuates painful diabetic neuropathy via inhibiting microglia pyroptosis

  2024cites this paper
• A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model

  2024influential citation
• Preclinical Evaluation of Sigma 1 Receptor Antagonists as a Novel Treatment for Painful Diabetic Neuropathy.

  2024cites this paper
• Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary

  2024cites this paper
• What is associated with painful polyneuropathy? A cross-sectional analysis of symptoms and signs in patients with painful and painless polyneuropathy

  2024cites this paper
• Eleven neurology-related proteins measured in serum are positively correlated to the severity of diabetic neuropathy

  2024cites this paper
• Prevalence of painful and painless diabetic peripheral neuropathy in the Northern Danish Region: A population-based study.

  2024cites this paper
• Kv7 Channel Activators Flupirtine and ML213 Alleviate Neuropathic Pain Behavior in the Streptozotocin Rat Model of Diabetic Neuropathy

  2024cites this paper
• Presence of Subclinical Polyneuropathy in Patients with Elevation of Hba1c.

  2024cites this paper
• Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system

  2024cites this paper
• Neuropathies chez les diabétiques

  2024cites this paper
• Genetic Variants Influence the Development of Diabetic Neuropathy

  2024cites this paper
• Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study

  2024cites this paper
• Prevalence and Risk Factors of Distal Symmetric Polyneuropathy Among Predominantly Non-Hispanic Black, Low-Income Patients.

  2024cites this paper
• Increased thalamocortical functional connectivity on discontinuation of treatment in painful diabetic peripheral neuropathy.

  2024cites this paper
• Diabetic peripheral neuropathy: age-stratified glycemic control

  2024cites this paper
• The effect of aromatherapy on pain in individuals with diabetes: a systematic review and meta-analysis

  2024cites this paper
• A Cross-sectional Study to Evaluate the Efficacy and Safety of Pregabalin Use in Young Adults of a Tertiary Care Indian Setting

  2024cites this paper
• Neuropatie nei diabetici

  2024cites this paper
• The analgesic effects of insulin and its disorders in streptozotocin‐induced short‐term diabetes

  2024cites this paper
• Dysphagia as a Manifestation of Endocrine and Metabolic Disorders.

  2024cites this paper
• Major adverse foot events and functional mobility deficits associated with diabetic neuropathy and nephropathy

  2024cites this paper
• Neuropathic Pain, Mood, and Stress-Related Disorders: A Literature Review of Comorbidity and Co-Pathogenesis.

  2024cites this paper
• System Biology Approaches for Systemic Diseases: Emphasis on Type II Diabetes Mellitus and Allied Metabolism

  2024cites this paper
• Dosing Time-Dependent Difference in the Suppressive Effect of Empagliflozin on the Development of Mechanical Pain Hypersensitivity in Diabetic Mice

  2024cites this paper
• Electrodiagnostic studies and new diagnostic modalities for evaluation of peripheral nerve disorders

  2024cites this paper
• Stimulatory effect of methylglyoxal on capsaicin-sensitive lung vagal afferents in rats: role of TRPA1.

  2024cites this paper
• Diabetic peripheral neuropathy among adult type 2 diabetes patients in Adama, Ethiopia: health facility-based study

  2024cites this paper